ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Rongqian Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0993-4531; OpenAlex author ID A5014185339. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer cells. Last author DOI 10.1016/j.ejphar.2024.176462 ↗
An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer. Last author DOI 10.3389/fgene.2023.1084275 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wuming Liu · 1 shared paper, 2024 · strength 0.21
- Paper MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer … DOI 10.1016/j.ejphar.2024.176462 ↗
Zheng Wu · 1 shared paper, 2024 · strength 0.21
- Paper MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer … DOI 10.1016/j.ejphar.2024.176462 ↗
Jie Hao · 1 shared paper, 2023 · strength 0.20
- Paper An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pan… DOI 10.3389/fgene.2023.1084275 ↗
Cancan Zhou · 1 shared paper, 2023 · strength 0.20
- Paper An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pan… DOI 10.3389/fgene.2023.1084275 ↗
Zhenhua Ma · 1 shared paper, 2023 · strength 0.20
- Paper An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pan… DOI 10.3389/fgene.2023.1084275 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.